|
Name |
3β,20-dihydroxy-protosta-16,24-dien-29-oic acid
|
Molecular Formula | C30H48O4 | |
IUPAC Name* |
3-hydroxy-17-(2-hydroxy-6-methylhept-5-en-2-yl)-4,8,10,14-tetramethyl-2,3,5,6,7,9,11,12,13,15-decahydro-1H-cyclopenta[a]phenanthrene-4-carboxylicacid
|
|
SMILES |
CC(C)=CCCC(C)(O)C1=CCC2(C)C1CCC1C3(C)CCC(O)C(C)(C(=O)O)C3CCC12C
|
|
InChI |
InChI=1S/C30H48O4/c1-19(2)9-8-15-29(6,34)21-12-17-27(4)20(21)10-11-22-26(3)16-14-24(31)30(7,25(32)33)23(26)13-18-28(22,27)5/h9,12,20,22-24,31,34H,8,10-11,13-18H2,1-7H3,(H,32,33)/t20-,22-,23+,24-,26+,27-,28-,29?,30+/m0/s1
|
|
InChIKey |
VLDXQMCAKXKUGY-ZSFARPFBSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 472.71 | ALogp: | 6.5 |
HBD: | 3 | HBA: | 3 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 77.8 | Aromatic Rings: | 4 |
Heavy Atoms: | 34 | QED Weighted: | 0.401 |
Caco-2 Permeability: | -5.228 | MDCK Permeability: | 0.00001570 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.074 | 20% Bioavailability (F20%): | 0.675 |
30% Bioavailability (F30%): | 0.098 |
Blood-Brain-Barrier Penetration (BBB): | 0.968 | Plasma Protein Binding (PPB): | 98.37% |
Volume Distribution (VD): | 0.821 | Fu: | 3.24% |
CYP1A2-inhibitor: | 0.007 | CYP1A2-substrate: | 0.269 |
CYP2C19-inhibitor: | 0.011 | CYP2C19-substrate: | 0.903 |
CYP2C9-inhibitor: | 0.074 | CYP2C9-substrate: | 0.362 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.11 |
CYP3A4-inhibitor: | 0.145 | CYP3A4-substrate: | 0.179 |
Clearance (CL): | 5.932 | Half-life (T1/2): | 0.024 |
hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.204 |
Drug-inuced Liver Injury (DILI): | 0.01 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.198 | Maximum Recommended Daily Dose: | 0.578 |
Skin Sensitization: | 0.042 | Carcinogencity: | 0.195 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.031 |
Respiratory Toxicity: | 0.942 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005284 | 0.471 | D0X7XG | 0.387 | ||||
ENC002152 | 0.460 | D0B4RU | 0.292 | ||||
ENC000865 | 0.412 | D03MTN | 0.281 | ||||
ENC005283 | 0.400 | D0Q6NZ | 0.276 | ||||
ENC001478 | 0.387 | D03ZTE | 0.273 | ||||
ENC001833 | 0.376 | D0G3SH | 0.273 | ||||
ENC002246 | 0.370 | D0M4WA | 0.272 | ||||
ENC001918 | 0.361 | D0W5LS | 0.272 | ||||
ENC001582 | 0.357 | D0U3GL | 0.267 | ||||
ENC002119 | 0.346 | D0I2SD | 0.262 |